D.
4576.TD. Western Therapeutics Institute, Inc. Price (4576.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
35,118,450
(10.5047)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. The company offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; DWR-2206, a regenerative medicine cell-product for bullous keratopathy; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining. It is also developing DW-5LBT, a lidocaine patch for neuropathic pain after shingles; K-321 to treat fuch... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $60-254
- Market Cap 5.34B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Yuichi Hidaka
- IPO Date: October, 23, 2009
- Country: JP
- Currency: JPY
- Headquaters: No Data
- Employees: 21
- Revenue from each product or segment:
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|
- Revenue by Region
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|